BPC-157 vs Glutamine for digestion
Short answer: For digestion, more users report improvement with Glutamine — 100% of 11 reports, versus 84% of 111 for BPC-157.
BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; Glutamine has 361 and 787.
Based on 1,613 reports about BPC-157 and 146 about Glutamine. Not medical advice.
| BPC-157 Peptide | Glutamine Supplement | |
|---|---|---|
| Users say it helped | 54%helped919 reports · high confidence | 37%helped55 reports · medium confidence |
| Verdict | Mixed | Mixed |
| Research | DResearch: None | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 0 | 361 / 787 |
| Mainly used for | ||
| Recovery % reporting improvement | 96% (494) | 100% (11) |
| Pain & inflammation % reporting improvement | 86% (485) | 100% (3) |
| Mood % reporting improvement | 65% (128) | 67% (3) |
| Digestion % reporting improvement | 84% (111) | 100% (11) |
| Sleep % reporting improvement | 80% (76) | 50% (2) |
| Common side effects | fatigue, anhedonia, anxiety, headache | urine odor, headache, vivid dreams, stomach issues |
| Typical dose reported | Not listed | 5 mg / before bed |
BPC-157Full BPC-157 profile →
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
GlutamineFull Glutamine profile →
Latest review conclusion
In studies using high-throughput metabolomics, several blood amino acids appear to be consistently associated with the risk of developing type 2 diabetes.
Diabetes Care, 2016 ↗What a user said
“amino acids L carnitine and glutamine made a difference in my skin.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate